| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10018026 | HBV | ENSG00000166006.14 | protein_coding | KCNC2 | No | No | 3747 | Q96PR1 |
| TVIS10018031 | HBV | ENSG00000166006.14 | protein_coding | KCNC2 | No | No | 3747 | Q96PR1 |
| TVIS10018032 | HBV | ENSG00000166006.14 | protein_coding | KCNC2 | No | No | 3747 | Q96PR1 |
| TVIS10019740 | HBV | ENSG00000166006.14 | protein_coding | KCNC2 | No | No | 3747 | Q96PR1 |
| TVIS10020534 | HBV | ENSG00000166006.14 | protein_coding | KCNC2 | No | No | 3747 | Q96PR1 |
| TVIS20066344 | HPV | ENSG00000166006.14 | protein_coding | KCNC2 | No | No | 3747 | Q96PR1 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | KCNC2 |
|---|---|
| DrugBank ID | DB06637 |
| Drug Name | Dalfampridine |
| Target ID | BE0004724 |
| UniProt ID | Q96PR1 |
| Regulation Type | antagonist |
| PubMed IDs | 16472864 |
| Citations | Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. |
| Groups | Approved |
| Direct Classification | Aminopyridines and derivatives |
| SMILES | NC1=CC=NC=C1 |
| Pathways | |
| PharmGKB | PA166123389 |
| ChEMBL | CHEMBL284348 |
